PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB
Want to see PDSB full AI Analyst Report?
Total Valuation
PDS Biotechnology has a market cap or net worth of $51.91M. The enterprise value is $5.23B.
Market Cap$51.91M
Enterprise Value$5.23B
Share Statistics
PDS Biotechnology has 55,815,655 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding55,815,655
Owned by Insiders1.51%
Owned by Institutions0.37%
Financial Efficiency
PDS Biotechnology’s return on equity (ROE) is -3.73 and return on invested capital (ROIC) is -0.59%.
Return on Equity (ROE)-3.73
Return on Assets (ROA)-1.13
Return on Invested Capital (ROIC)-0.59%
Return on Capital Employed (ROCE)-1.50
Revenue Per Employee0.00
Profits Per Employee-1.44B
Employee Count24
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PDS Biotechnology is ―. PDS Biotechnology’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.00
PB Ratio3.86
Price to Fair Value3.86
Price to FCF>-0.01
Price to Operating Cash Flow-1.51
PEG Ratio0.04
Income Statement
In the last 12 months, PDS Biotechnology had revenue of 0.00 and earned -34.50M in profits. Earnings per share was -0.74.
Revenue0.00
Gross Profit-60.52K
Operating Income-31.54M
Pretax Income-35.67M
Net Income-34.50M
EBITDA-30.30M
Earnings Per Share (EPS)-0.74
Cash Flow
In the last 12 months, operating cash flow was -27.75M and capital expenditures 8.00, giving a free cash flow of -27.75M billion.
Operating Cash Flow-27.75M
Free Cash Flow-27.75M
Free Cash Flow per Share-0.50
Dividends & Yields
PDS Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.96
52-Week Price Change-22.86%
50-Day Moving Average0.74
200-Day Moving Average0.95
Relative Strength Index (RSI)76.50
Average Volume (3m)850.16K
Important Dates
PDS Biotechnology upcoming earnings date is May 20, 2026, TBA (Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
PDS Biotechnology as a current ratio of 2.82, with Debt / Equity ratio of 56121.04%
Current Ratio2.82
Quick Ratio2.82
Debt to Market Cap145.02
Net Debt to EBITDA-170.45
Interest Coverage Ratio-5.91
Taxes
In the past 12 months, PDS Biotechnology has paid -1.17M in taxes.
Income Tax-1.17M
Effective Tax Rate0.03
Enterprise Valuation
PDS Biotechnology EV to EBITDA ratio is -171.63, with an EV/FCF ratio of -0.19.
EV to Sales0.00
EV to EBITDA-171.63
EV to Free Cash Flow-0.19
EV to Operating Cash Flow-0.19
Balance Sheet
PDS Biotechnology has $26.71M in cash and marketable securities with $5.19B in debt, giving a net cash position of -$5.17B billion.
Cash & Marketable Securities$26.71M
Total Debt$5.19B
Net Cash-$5.17B
Net Cash Per Share-$92.55
Tangible Book Value Per Share$0.20
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PDS Biotechnology is $7.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$7.50
Price Target Upside472.52% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast27.64%